Features | Partner Sites | Information | LinkXpress
Sign In
Advantech Europe
Schiller
GLOBETECH PUBLISHING

Transapical Technology Facilitates Cardiac Surgery

By HospiMedica International staff writers
Posted on 15 Oct 2013
Image: The Apica ASC system (Photo courtesy of Apica Cardiovascular).
Image: The Apica ASC system (Photo courtesy of Apica Cardiovascular).
A new surgical platform allows the delivery of aortic and mitral valves through the chest wall and the apex of the beating heart.

The Access, Stabilization, and Closure (ASC) system, in conjunction with minimally invasive surgical (MIS) techniques is used to deliver large-bore therapeutic devices into the beating heart of patients with structural heart disease, via the cardiac apex. The system both seals and stabilizes the tissue of the access site during therapeutic device delivery, minimizing loss of blood from, or induction of air to the beating heart. On completion of the therapeutic treatment, it standardizes apical access and closure, leading to safer heart operations, decreased procedure time, and reduced technical challenges associated with transapical access and closure.

A multicenter clinical trial conducted in Germany of the ASC system demonstrated an excellent safety profile with 100% technical success, superior ease-of-use for surgeons, and reductions in both blood loss and operative time. Follow-up assessments of patients showed that the system provided robust closure, with no postoperative apical bleeding complications and no degradation of left ventricular function. The ASC system is a product of Apica Cardiovascular (Galway, Ireland), and has received the European community CE marking of approval.

“Clinically, the Apica ASC System is easy to use, standardizing apical access and closure. Its ‘sutureless’ access coil minimizes both rib spreading and patient pain, providing a dry access site with no peri-sheath bleeding,” said Prof. Thomas Walther, MD, of the Kerckhoff Klinik (Hamburg, Germany), who participated in the device’s clinical study. “Apical closure was reliable, rapid, and completely dry, demonstrating a reduction in operative times, blood loss, use of blood products and apical access site complications.”

“Apica has provided an excellent example of how a new medical device, which was initially conceived and developed overseas, could be brought to Ireland and developed here so that it can be made available for export to treat patients globally,” said James Greene, CEO of Apica Cardiovascular.

The transapical transcatheter aortic valve implantation (TAVI) approach is used for patients whose arteries are too small or too diseased for the transfemoral approach. The delivery system is designed for replacement valve implantation via the apex of the heart, which is reached through a small incision made between the ribs just below the left nipple. It is then expanded using a balloon to fit across the stenotic aortic valve, holding it open permanently.

Related Links:

Apica Cardiovascular



Anetic Aid
ECR
Cincinnati Sub-Zero

Channels

Women's Health

view channel

Maternal Iron Intake Linked to Autism Risk

A new study reveals that mothers of children with autism spectrum disorder (ASD) are less likely to have taken iron supplements before and during their pregnancies. Researchers at the University of California Davis (UCD; USA) and the UCD Mind Institute Clinic (Sacramento, CA, USA) analyzed data from 866 mother-child... Read more

Health IT

view channel

Doctors Claim EHRs Do Not Save Money or Time

A recent survey claims that 75% of physicians in the United States who use electronic health records (EHRs) say they are not cost- or time-effective, but do have value in terms of providing data. The Deloitte (New York, NY, USA) 2014 Survey examined US physicians’ current use and overall views of mobile health (mHealth)... Read more

Hospital News

view channel

Apollo Hospitals Opens New Diabetes Clinics

Apollo Hospitals (Kolkata, India) has partnered with pharmaceutical giant Sanofi (Paris, France) to improve access to treatment for diabetics. The joint venture, to be named Apollo Sugar Clinics, will be a subsidiary of Apollo Health and Lifestyle, with Sanofi proposing to buy a 20% stake. For the first phase of the... Read more

Business

view channel

Growth Expected for Global Patient Monitoring Market

The global advanced patient monitoring market has benefited from demand at health facilities and in the home treatment markets. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm. The global advanced patient monitoring market includes equipment and devices... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.